GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kopran Ltd (NSE:KOPRAN) » Definitions » Gross-Profit-to-Asset %

Kopran (NSE:KOPRAN) Gross-Profit-to-Asset % : 28.85% (As of Sep. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Kopran Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Kopran's annualized Gross Profit for the quarter that ended in Sep. 2024 was ₹2,156 Mil. Kopran's average Total Assets over the quarter that ended in Sep. 2024 was ₹7,475 Mil. Therefore, Kopran's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 was 28.85%.


Kopran Gross-Profit-to-Asset % Historical Data

The historical data trend for Kopran's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kopran Gross-Profit-to-Asset % Chart

Kopran Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.97 41.24 36.21 27.63 27.84

Kopran Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.43 34.97 21.26 28.81 28.85

Competitive Comparison of Kopran's Gross-Profit-to-Asset %

For the Drug Manufacturers - General subindustry, Kopran's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kopran's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kopran's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Kopran's Gross-Profit-to-Asset % falls into.



Kopran Gross-Profit-to-Asset % Calculation

Kopran's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=1938.75/( (6496.989+7432.462)/ 2 )
=1938.75/6964.7255
=27.84 %

Kopran's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=2156.456/( (0+7474.639)/ 1 )
=2156.456/7474.639
=28.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Kopran Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Kopran's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kopran Business Description

Traded in Other Exchanges
Address
Dr. E. Moses Road, 1076, Parijat House, Worli, Mumbai, MH, IND, 400 018
Kopran Ltd is an Indian based pharmaceutical company. It is engaged in manufacturing of Formulation (Finished Dosage Form) and Active Pharmaceutical Ingredients (API) i.e., Pharmaceuticals. It manufactures dosage forms including, tablets, capsules, dry powder, suspension, and injectables. Some of its product range includes antibiotics, cardiovascular, anti-diabetes, respiratory, pain management, and gastrointestinal. Geographically, it has a presence in India; South Africa; Ethiopia; Zambia; Egypt; Jordan and Rest of World.

Kopran Headlines

No Headlines